---
layout: entry
title: "Emergence of Institutional Antithrombotic Protocols for Coronavirus 2019"
link: "https://doi.org/10.1002/rth2.12358"
author:
- Cohoon, Kevin P.; Mah??, Guillaume; Tafur, Alfonso J.; Spyropoulos, Alex C.

summary:
- "COVID-19 is an acute infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) Similar events have occurred during other viral outbreaks. Similar thromboembolic events occur during other outbreaks, including severe respiratory syndrome. The outbreak has contributed to significant morbidity and mortality, including the development of coagulopathy. Thrombotic and thromogenic events have been reported in other viral cases. COV-19 is a major public health crisis with new infections in Wuhan, China, a severe infectious disease. caused by. the severe. severe acute."

original:
- "The coronavirus infection (COVID-19), first identified in December 2019 in Wuhan, China, is a major public health crisis with new infections increasing exponentially worldwide. COVID-19 is an acute infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and has contributed to significant morbidity and mortality, including the development of coagulopathy. Similar thrombotic and thromboembolic events have occurred during other viral outbreaks, including severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome (MERS-CoV), and influenza A H1N1."
---

